Alzamend Neuro (ALZN) Total Debt (2020 - 2024)
Alzamend Neuro's (ALZN) quarterly Total Debt came in at $300714.0 in Q2 2024, down 69.6% quarter-over-quarter from $989334.0 in Q4 2022.
Analysis
Alzamend Neuro (ALZN) Total Debt (2020 - 2024) Analysis & Trends
Alzamend Neuro has disclosed Total Debt across 4 years of filings, most recently posting $300714.0 for Q2 2024.
- In Q2 2024, Total Debt changed N/A year-over-year to $300714.0; the TTM figure through Apr 2024 stood at $300714.0 (changed N/A YoY), while the FY2024 annual figure was $300714.0, changed N/A from the prior year.
- Total Debt came in at $300714.0 for Q2 2024 at Alzamend Neuro, down from $989334.0 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $989334.0 in Q4 2022 to a low of $2082.0 in Q1 2022.
- Average Total Debt over 4 years is $185069.9, with a median of $60749.0 recorded in 2021.
- The largest YoY upside for Total Debt was 45240.7% in 2022 against a maximum downside of 96.57% in 2022.
- Over 4 years, Total Debt stood at $62667.0 in 2020, then plunged by 96.52% to $2182.0 in 2021, then soared by 45240.7% to $989334.0 in 2022, then slumped by 69.6% to $300714.0 in 2024.
- Per Business Quant data, the three most recent Total Debt figures were $300714.0 in Q2 2024, $989334.0 in Q4 2022, and $2082.0 in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.68 Bn | 193.69 Bn | 7.24 Bn | 62.75 Bn |
| 2 | Gilead Sciences | 178.73 Bn | 175.55 Bn | 6.22 Bn | 28.66 Bn |
| 3 | Vertex Pharmaceuticals | 131.05 Bn | 123.20 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.79 Bn | 73.80 Bn | 3.93 Bn | 1.99 Bn |
| 5 | Argenx Se | 60.99 Bn | 55.81 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.41 Bn | 48.27 Bn | 52.00 Mn | 591.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.10 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.72 Bn | 30.43 Bn | 1.96 Bn | 8.09 Bn |
| 9 | Roivant Sciences | 29.53 Bn | 29.53 Bn | 1.16 Mn | - |
| 10 | Alzamend Neuro | 5.57 Mn | 5.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2024 | 300,714.00 |
| Oct 31, 2022 | 989,334.00 |
| Apr 30, 2022 | 2,082.00 |
| Jan 31, 2022 | 2,082.00 |
| Oct 31, 2021 | 2,182.00 |
| Jul 31, 2021 | 60,749.00 |
| Apr 30, 2021 | 60,749.00 |
| Apr 30, 2020 | 62,667.00 |